Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S; PRASFIT-Elective Investigators. Isshiki T, et al. Among authors: nishikawa m. Circ J. 2014;78(12):2926-34. doi: 10.1253/circj.cj-14-0266. Epub 2014 Oct 21. Circ J. 2014. PMID: 25342212 Free article. Clinical Trial.
Impact of Arterial Access Route on Bleeding Complications in Japanese Patients Undergoing Percutaneous Coronary Intervention- Insight From the PRASFIT Trial.
Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nishikawa M, Miyazaki S, Tanaka Y, Nakamura M; PRASFIT-ACS and PRASFIT-Elective Investigators. Saito S, et al. Among authors: nishikawa m. Circ J. 2015;79(9):1928-37. doi: 10.1253/circj.CJ-15-0276. Epub 2015 Jun 4. Circ J. 2015. PMID: 26040334 Free article. Clinical Trial.
No association between on-treatment platelet reactivity and bleeding events following percutaneous coronary intervention and antiplatelet therapy: A post hoc analysis.
Nishikawa M, Isshiki T, Kimura T, Ogawa H, Yokoi H, Miyazaki S, Ikeda Y, Nakamura M, Takita A, Saito S; PRASFIT-ACS (PRASugrel compared with clopidogrel For Japanese patIenTs with Acute Coronary Syndrome undergoing percutaneous coronary intervention) Investigators. Nishikawa M, et al. Thromb Res. 2015 Nov;136(5):947-54. doi: 10.1016/j.thromres.2015.09.014. Epub 2015 Sep 21. Thromb Res. 2015. PMID: 26460279 Free article. Clinical Trial.
Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study.
Ogawa H, Isshiki T, Kimura T, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Tanaka Y, Saito S. Ogawa H, et al. Among authors: nishikawa m. J Cardiol. 2016 Jul;68(1):29-36. doi: 10.1016/j.jjcc.2015.07.019. Epub 2015 Oct 29. J Cardiol. 2016. PMID: 26521100 Free article. Clinical Trial.
A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trial.
Nagao T, Toyoda K, Kitagawa K, Kitazono T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y, Ogawa A. Nagao T, et al. Among authors: nishikawa m. Expert Opin Pharmacother. 2018 Apr;19(6):529-535. doi: 10.1080/14656566.2018.1444029. Epub 2018 Mar 26. Expert Opin Pharmacother. 2018. PMID: 29463150 Clinical Trial.
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y; PRASTRO-I Study Group. Ogawa A, et al. Among authors: nishikawa m. Lancet Neurol. 2019 Mar;18(3):238-247. doi: 10.1016/S1474-4422(18)30449-6. Epub 2019 Feb 12. Lancet Neurol. 2019. PMID: 30784555 Clinical Trial.
Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation.
Nishikawa M, Takeda Y, Isomura N, Tanigawa T, Nanasato M, Tsukahara K, Kimura K, Takayama T, Hirayama A, Kato M, Nishikawa H, Nishimura Y, Isshiki T, Yokoi H; j-CHIPS group. Nishikawa M, et al. Among authors: nishikawa h. J Atheroscler Thromb. 2020 Jan 1;27(1):13-24. doi: 10.5551/jat.48934. Epub 2019 May 14. J Atheroscler Thromb. 2020. PMID: 31092743 Free PMC article.
2,362 results